GRIFOLS SA-ADR (GRFS) Stock Overview
USA - NASDAQ:GRFS - US3984384087 - ADR
GRFS Key Statistics, Chart & Performance
The current stock price of GRFS is 10.02 USD. In the past month the price increased by 1.21%. In the past year, price increased by 12.33%.
GRFS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 22.34 | 417.90B | ||
| AMGN | AMGEN INC | 13.64 | 160.11B | ||
| GILD | GILEAD SCIENCES INC | 14.28 | 137.18B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 24.14 | 104.83B | ||
| REGN | REGENERON PHARMACEUTICALS | 13.15 | 63.59B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 60.43B | ||
| ARGX | ARGENX SE - ADR | 85.39 | 48.45B | ||
| ONC | BEONE MEDICINES LTD-ADR | 6.03 | 41.03B | ||
| INSM | INSMED INC | N/A | 32.30B | ||
| BNTX | BIONTECH SE-ADR | N/A | 25.12B | ||
| BIIB | BIOGEN INC | 9.7 | 22.76B | ||
| NTRA | NATERA INC | N/A | 21.99B |
Related stock screener links
About GRFS
Company Profile
Grifols SA engages in the production of plasma derivatives. The company is headquartered in Sant Cugat Del Valles, Barcelona and currently employs 23,833 full-time employees. The company went IPO on 2006-05-17. The firm organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.
Company Info
GRIFOLS SA-ADR
Parque Empresarial Can Sant Joan, Avinguda de la Generalitat, 152-158
Sant Cugat del Valles BARCELONA 08174 ES
CEO: Raimon Grifols Roura
Employees: 23833
Phone: 34935710000
GRIFOLS SA-ADR / GRFS FAQ
What is the stock price of GRIFOLS SA-ADR today?
The current stock price of GRFS is 10.02 USD. The price increased by 0.5% in the last trading session.
What is the ticker symbol for GRIFOLS SA-ADR stock?
The exchange symbol of GRIFOLS SA-ADR is GRFS and it is listed on the Nasdaq exchange.
On which exchange is GRFS stock listed?
GRFS stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for GRIFOLS SA-ADR stock?
20 analysts have analysed GRFS and the average price target is 13.55 USD. This implies a price increase of 35.28% is expected in the next year compared to the current price of 10.02. Check the GRIFOLS SA-ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is GRIFOLS SA-ADR worth?
GRIFOLS SA-ADR (GRFS) has a market capitalization of 6.82B USD. This makes GRFS a Mid Cap stock.
How many employees does GRIFOLS SA-ADR have?
GRIFOLS SA-ADR (GRFS) currently has 23833 employees.
What are the support and resistance levels for GRIFOLS SA-ADR (GRFS) stock?
GRIFOLS SA-ADR (GRFS) has a support level at 10 and a resistance level at 10.7. Check the full technical report for a detailed analysis of GRFS support and resistance levels.
Is GRIFOLS SA-ADR (GRFS) expected to grow?
The Revenue of GRIFOLS SA-ADR (GRFS) is expected to grow by 5.62% in the next year. Check the estimates tab for more information on the GRFS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy GRIFOLS SA-ADR (GRFS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of GRFS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of GRFS, evaluating the profitability, health, valuation and growth aspects
- GRIFOLS SA-ADR (GRFS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- GRIFOLS SA-ADR (GRFS) Sales and EPS estimates to see what analysts future expectations are.
- GRIFOLS SA-ADR (GRFS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- GRIFOLS SA-ADR (GRFS) Insider and Institutional Ownership to learn about the owners and their transactions.
- GRIFOLS SA-ADR (GRFS) Stock Chart to make your own analysis
- GRIFOLS SA-ADR (GRFS) Latest news and press-releases to stay up to date.
Does GRIFOLS SA-ADR (GRFS) stock pay dividends?
GRIFOLS SA-ADR (GRFS) has a dividend yield of 4.15%. The yearly dividend amount is currently 0. Check the full fundamental report for a detailed analysis of GRFS dividend history, reliability and sustainability.
When does GRIFOLS SA-ADR (GRFS) report earnings?
GRIFOLS SA-ADR (GRFS) will report earnings on 2025-11-05.
What is the Price/Earnings (PE) ratio of GRIFOLS SA-ADR (GRFS)?
The PE ratio for GRIFOLS SA-ADR (GRFS) is 19.27. This is based on the reported non-GAAP earnings per share of 0.52 and the current share price of 10.02 USD. Check the full fundamental report for a full analysis of the valuation metrics for GRFS.
What is the Short Interest ratio of GRIFOLS SA-ADR (GRFS) stock?
The outstanding short interest for GRIFOLS SA-ADR (GRFS) is 1.86% of its float. Check the ownership tab for more information on the GRFS short interest.
GRFS Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to GRFS. When comparing the yearly performance of all stocks, GRFS is one of the better performing stocks in the market, outperforming 70.48% of all stocks.
GRFS Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to GRFS. GRFS has an excellent profitability rating, but there are some minor concerns on its financial health.
GRFS Financial Highlights
Over the last trailing twelve months GRFS reported a non-GAAP Earnings per Share(EPS) of 0.52. The EPS increased by 110.19% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.99% | ||
| ROA | 1.5% | ||
| ROE | 5.75% | ||
| Debt/Equity | 1.76 |
GRFS Forecast & Estimates
20 analysts have analysed GRFS and the average price target is 13.55 USD. This implies a price increase of 35.28% is expected in the next year compared to the current price of 10.02.
For the next year, analysts expect an EPS growth of 46.39% and a revenue growth 5.62% for GRFS